Serial magnetic resonance imaging in active surveillance of prostate cancer: Incremental value

Journal of Urology

Volumn 195, Issue 5, 2016, Pages 1421-1427

  Felker, Ely R ^a   Wu, Jason ^b   Natarajan, Shyam ^b,c   Margolis, Daniel J ^a   Raman, Steven S ^a   Huang, Jiaoti ^b   Dorey, Fred ^b   Marks, Leonard S ^b  

^a UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Engineering IV   (United States)

Author keywords

magnetic resonance imaging; prostatic neoplasms; watchful waiting

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL STUDY; COHORT ANALYSIS; FOLLOW UP; GLEASON SCORE; HUMAN; MALE; MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; VERY ELDERLY; CALIFORNIA; CANCER REGISTRY; DISEASE COURSE; IMAGE GUIDED BIOPSY; INCIDENCE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; PROSTATE; PROSTATIC NEOPLASMS; RISK ASSESSMENT; TIME FACTOR; WATCHFUL WAITING;

AGED; AGED, 80 AND OVER; CALIFORNIA; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; IMAGE-GUIDED BIOPSY; INCIDENCE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSTATE; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; ROC CURVE; SEER PROGRAM; TIME FACTORS; WATCHFUL WAITING;

EID: 84962956052     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2015.11.055     Document Type: Article

References (22)

1. R. Siegel, J. Ma, Z. Zou, and et al. Cancer statistics, 2014 CA Cancer J Clin 64 2014 9
2. C.P. Filson, L.S. Marks, and M.S. Litwin Expectant management for men with early stage prostate cancer CA Cancer J Clin 65 2015 264
3. R.K. Berglund, T.A. Masterson, K.C. Vora, and et al. Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance J Urol 180 2008 1964
4. P.A. Pinto, P.H. Chung, A.R. Rastinehad, and et al. Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging J Urol 186 2011 1281
5. S. Vourganti, A. Rastinehad, N.K. Yerram, and et al. Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies J Urol 188 2012 2152
6. J.C. Hu, E. Chang, S. Natarajan, and et al. Targeted prostate biopsy in select men for active surveillance: do the Epstein criteria still apply? J Urol 192 2014 385
7. C.M. Moore, N. Petrides, and M. Emberton Can MRI replace serial biopsies in men on active surveillance for prostate cancer? Curr Opin Urol 24 2014 280
8. D. Bonekamp, S. Bonekamp, J.K. Mullins, and et al. Multiparametric magnetic resonance imaging characterization of prostate lesions in the active surveillance population: incremental value of magnetic resonance imaging for prediction of disease reclassification J Comput Assist Tomogr 37 2013 948
9. S. Rais-Bahrami, B. Türkbey, A.R. Rastinehad, and et al. Natural history of small index lesions suspicious for prostate cancer on multiparametric MRI: recommendations for interval imaging follow-up Diagn Interv Radiol 20 2014 293
10. A. Walton Diaz, N.A. Shakir, A.K. George, and et al. Use of serial multiparametric magnetic resonance imaging in the management of patients with prostate cancer on active surveillance Urol Oncol 33 2015 202
11. A.B. Rosenkrantz, S.L. Rice, N.E. Wehrli, and et al. Association between changes in suspicious prostate lesions on serial MRI examinations and follow-up biopsy results Clin Imaging 39 2015 264
12. D.J. Bryk, E. Llukani, W.C. Huang, and et al. Natural history of pathologically benign cancer suspicious regions on multiparametric magnetic resonance imaging following targeted biopsy J Urol 194 2015 1234
13. G.A. Sonn, S. Natarajan, D.J. Margolis, and et al. Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device J Urol 189 2013 86
14. M. Kamrava, M. Chung, S. Mesko, and et al. Correlation of quantitative diffusion-weighted and dynamic contrast-enhanced MRI parameters with NCCN risk group, Gleason score, and maximum tumor diameter in prostate cancer Pract Radiat Oncol 3 suppl. 2013 S4
15. S. Natarajan, L.S. Marks, D.J. Margolis, and et al. Clinical application of a 3D ultrasound-guided prostate biopsy system Urol Oncol 29 2011 334
16. J.I. Epstein, P.C. Walsh, M. Carmichael, and et al. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer JAMA 271 1994 368
17. T. Matsugasumi, E. Baco, S. Palmer, and et al. Prostate cancer volume estimation by combining magnetic resonance imaging and targeted biopsy proven cancer core length: correlation with cancer volume J Urol 194 2015 957
18. M.R. Cooperberg, P.R. Carroll, and L. Klotz Active surveillance for prostate cancer: progress and promise J Clin Oncol 29 2011 3669
19. H.B. Carter, A.W. Partin, P.C. Walsh, and et al. Gleason score 6 adenocarcinoma: should it be labeled as cancer? J Clin Oncol 30 2012 4294
20. E. Baco, O. Ukimura, E. Rud, and et al. Magnetic resonance imaging-transrectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients Eur Urol 67 2015 787
21. D.L. Langer, T.H. van der Kwast, A.J. Evans, and et al. Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2-sparse versus dense cancers Radiology 249 2008 900
22. H.U. Ahmed, Y. Hu, T. Carter, and et al. Characterizing clinically significant prostate cancer using template prostate mapping biopsy J Urol 186 2011 458